P1639: UTILITY OF NEXT GENERATION SEQUENCING TECHNIQUES TO EVALUATE POSSIBLE CAUSES OF REFRACTORINESS TO TREATMENT WITH ELTROMBOPAG IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYT...

por Gonzalez-Lopez, T. J., Sanchez, R., Pastoriza, C., Sanchez Gonzalez, B., Olivera, P., Bernat, S., Fernandez-Fuertes, F., Caparrós Miranda, I., Mingot, E., Pérez-Rus, G., Jarque, I., Moreno Beltrán, M. E., López Abadía, E., De Cabo, E., Marcellini, S., Pérez Segura, G., Fernández-Miñano, C., Peñarrubia, M. J., Alvarez, M., Fuertes Palacio, M. A., Martinez Lopez, J.
Publicado 2022

PB2307: A MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY OF ROMIPLOSTIM PLUS DEXAMETHASONE VS DEXAMETHASONE IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY IMMUNE THROMBOCYTOPENIA

por Mingot Castellano, M. E., Bradbury, C. A., Rosso Fernández, C., Thomas, I., Alvarez-Román, M. T., Canaro, M., Caparrós Miranda, I. S., Cappechi, M., Carpenedo, M., Evans, G., González-Lopéz, J. T., González-Porras, J. R., Jarque Ramos, I., Lozano-Almela, M. L., Lopez Fernandez, M. F., Lowe, G., Lyall, H., Pascual Izquierdo, C., Pavord, S., Rayment, R., Roberts, P., Rosique Cortina, P., Sánchez-González, B., Santoro, C., Talks, K., Valcarcel-Ferreiras, D., Zaja, F.
Publicado 2022